FDA Approved: MYFORTIC — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for MYFORTIC (mycophenolic acid) from Novartis. The approval expands its use for preventing organ rejection in kidne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation
• Kidney Transplantation
• Liver Transplantation

Drugs mentioned

• MYFORTIC (MYCOPHENOLIC ACID)

Snippet

SUPPL AP for MYFORTIC (MYCOPHENOLIC ACID)